Challenges met to produce a polymer-based artificial cornea

Article

A polymer-based corneal prosthesis has been developed by the Fraunhofer Institute for Applied Polymer Research (IAP), Postdam-Golm, as part of the EU's Artificial Cornea project.

A polymer-based corneal prosthesis has been developed by the Fraunhofer Institute for Applied Polymer Research (IAP), Postdam-Golm, as part of the EU’s Artificial Cornea Project.

To create the cornea cells of the surrounding tissue have to bond to the outer edge of the implant but no cells should adhere to the centre or vision would be impaired. It also had to be possible to wet the outer surface of the implant with tears to enable the patient to see through the artificial cornea and to allow the lid slide over it without friction.

To overcome these challenges the implant was coated in several polymers while also using a special protein at the edges, allowing the implant to bond with the naturally surrounding cells resulting in greater stability. For the outer surface of the artificial cornea a water-repellent material already in use in ophthalmic IOLs was applied.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.